Partial response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic BRAF V600EMT colon cancer patient with acquired C-MET amplification and TPM4-ALK fusion: a case report
@article{ACR9097, author = {Yingying Huang and Shuai Zhang and Xueqing Hu and Xiangyang Wang and Yunbo Zhao and Zhongkang Li}, title = {Partial response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic BRAF V600EMT colon cancer patient with acquired C-MET amplification and TPM4-ALK fusion: a case report}, journal = {AME Case Reports}, volume = {8}, number = {0}, year = {2024}, keywords = {}, abstract = {}, issn = {2523-1995}, url = {https://acr.amegroups.org/article/view/9097} }